Matches in Wikidata for { <http://www.wikidata.org/entity/Q73287864> ?p ?o ?g. }
Showing items 1 to 46 of
46
with 100 items per page.
- Q73287864 description "article scientifique publié en 1999" @default.
- Q73287864 description "artículu científicu espublizáu n'ochobre de 1999" @default.
- Q73287864 description "im Oktober 1999 veröffentlicher wissenschaftlicher Artikel" @default.
- Q73287864 description "scientific article published on 01 October 1999" @default.
- Q73287864 description "wetenschappelijk artikel" @default.
- Q73287864 description "наукова стаття, опублікована в жовтні 1999" @default.
- Q73287864 name "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 name "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 type Item @default.
- Q73287864 label "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 label "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 prefLabel "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 prefLabel "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 P1104 Q73287864-38B317D6-2685-4F17-BE52-D55391FAE7BE @default.
- Q73287864 P1433 Q73287864-CD0545DC-3160-4F41-B1A0-2843481FBF21 @default.
- Q73287864 P1476 Q73287864-ED51C0C0-F1A5-4312-B3CD-881CC9B83CB1 @default.
- Q73287864 P2093 Q73287864-5E838086-BE63-4912-83DF-A499664E3E66 @default.
- Q73287864 P2093 Q73287864-64F2D65B-C760-4E88-B8C4-CF5C3F2C9DBE @default.
- Q73287864 P2093 Q73287864-899492AA-B5BE-4A45-9C09-2C0D33DA258C @default.
- Q73287864 P2093 Q73287864-A2D39BE7-7B3E-4338-9D3A-CBBC742223B0 @default.
- Q73287864 P2093 Q73287864-E1126B56-96B3-4427-BE05-3CEAE892C94D @default.
- Q73287864 P304 Q73287864-D61B9393-3F27-4C28-B79F-AD51EEBF92EC @default.
- Q73287864 P31 Q73287864-5849C5F8-C4C6-40D9-B0FE-BAB267AFEDF4 @default.
- Q73287864 P433 Q73287864-BD308AFC-A508-428E-8932-C47B1F24A415 @default.
- Q73287864 P478 Q73287864-3B7965A4-3176-44D1-933A-29CA2B081DBB @default.
- Q73287864 P577 Q73287864-701F9D11-981B-47C1-B17C-349656C7B004 @default.
- Q73287864 P698 Q73287864-B2A1E29F-38F7-4EEB-BBA7-C90105823CE5 @default.
- Q73287864 P921 Q73287864-4629AD58-24AE-44A2-AED1-1AA23EB12FA4 @default.
- Q73287864 P921 Q73287864-F235D057-171A-41EB-A421-3ECC13893E4B @default.
- Q73287864 P698 10604271 @default.
- Q73287864 P1104 "+6" @default.
- Q73287864 P1433 Q14330412 @default.
- Q73287864 P1476 "Docetaxel (Taxotere) and estramustine versus mitoxantrone and prednisone for hormone-refractory prostate cancer: scientific basis and design of Southwest Oncology Group Study 9916" @default.
- Q73287864 P2093 "C Tangen" @default.
- Q73287864 P2093 "D Crawford" @default.
- Q73287864 P2093 "D Petrylak" @default.
- Q73287864 P2093 "E Fisher" @default.
- Q73287864 P2093 "M Hussain" @default.
- Q73287864 P304 "55-60" @default.
- Q73287864 P31 Q13442814 @default.
- Q73287864 P433 "5 Suppl 17" @default.
- Q73287864 P478 "26" @default.
- Q73287864 P577 "1999-10-01T00:00:00Z" @default.
- Q73287864 P698 "10604271" @default.
- Q73287864 P921 Q181257 @default.
- Q73287864 P921 Q420436 @default.